Susceptibility Testing Guide
Based on the Journal of Antimicrobial Chemotherapy Supplement (JAC [2001] 48, Suppl. S1).
Individual chapters are available below:
Chapter 1
History and development of antimicrobial susceptibility testing methodology
July 2001
Chapter 2
Determination of minimum inhibitory concentrations
March 2006
Chapter 3
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
January 2005
Chapter 4
The development of the BSAC standardized method of disc diffusion testing
July 2001
Chapter 5
BSAC standardized disc susceptibility testing method
April 2007
Chapter 6
Detection of beta-lactamase-mediated resistance
August 2005
Chapter 7
Detection of methicillin/oxacillian resistance in staphylococci
July 2001
Chapter 8
Quality assurance of antimicrobial susceptibility testing by disc diffusion
July 2001
Chapter 9
Recommendations for susceptibility tests on fastidious organisms and those requiring special handling
July 2001
Chapter 10
Instrumentation in antimicrobial susceptibility testing
July 2001
Chapter 11
Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes
March 2004
Latest News
Consultation on NICE Indicators: COPD
The consultation on proposed amendments and additions to the NICE indicators for COPD is open. This consultation presents amended and… Read more »
Cellulitis and erysipelas: antimicrobial prescribing NICE Draft guideline consultation
NICE Draft guideline consultation – Cellulitis and erysipelas: antimicrobial prescribing The draft guideline and supporting evidence on Cellulitis and erysipelas:… Read more »
NICE indicator process guide
Consultation on the updated NICE indicator process guide. Please note: the BSAC is inviting members to respond to this… Read more »
